Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
08:00am, Thursday, 08'th May 2025
SOUTH SAN FRANCISCO, Calif. & BOSTON--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care secto
Twist Bioscience: Expansion Efforts Continue To Face Challenges
02:18am, Wednesday, 07'th May 2025
Twist Bioscience reported solid results in Q2, but management's downbeat tone on the earnings call suggest there are challenges ahead. Twist has also spun-out its data storage business, which will hel
Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript
11:41am, Monday, 05'th May 2025
Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2025 Earnings Conference Call April 5, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust -
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
09:25am, Monday, 05'th May 2025
Twist Bioscience (TWST) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.79 per share a year ago.
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results
07:15am, Monday, 05'th May 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today
Twist Bioscience Spins Out DNA Data Storage as Independent Company
07:10am, Monday, 05'th May 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today
Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers
12:05pm, Thursday, 01'st May 2025
Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, Twis
Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System
08:00am, Thursday, 24'th Apr 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System.
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics
08:00am, Monday, 31'st Mar 2025
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
10:41am, Friday, 28'th Mar 2025
Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?
01:15pm, Wednesday, 12'th Mar 2025
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost
07:30am, Tuesday, 11'th Mar 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today
Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know
01:00pm, Thursday, 06'th Feb 2025
Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cathie Wood dumped Palantir to buy these biotech stocks
08:42am, Thursday, 06'th Feb 2025
Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure.
Twist Bioscience: Valuation Is Weighing On The Stock
11:30pm, Wednesday, 05'th Feb 2025
Twist Bioscience reported solid Q1 FY25 results, although this was insufficient to drive the company's share price higher. The demand environment remains challenging, and Trump's election has created
